Main department of treatment | Main disease | Number of the days from administration start date to diagnosis | Administered drug | Administration after diagnosis of ARONJ | Surgical procedure before administration of drug | Conservative therapy | Surgery |
Department of Allergy and Respiratory Medicine | Lung cancer | 188 | Zoledronic acid | Discontinuation | None | o | o |
Department of Hematology and Oncology | Myelodysplastic syndrome | 1318 | Risedronate | Continuation | None | | |
Department of Cardiovascular Medicine | Aortic stenosis Hypertrophic cardiomyopathy | 365 | Alendronate | Discontinuation | Tooth extraction | o | |
Breast and Endocrine Surgery Department | Breast cancer | 408 | Zoledronic acid | Continuation | Tooth extraction | o | |
Department of Allergy and Respiratory Medicine | Lung cancer | 92 | Denosumab | Continuation | Tooth extraction | o | |
Gastroenterology and Hepatology Department | Liver cancer | 175 | Zoledronic acid | Continuation | Tooth extraction | o | |
Urology | Prostatic cancer | 2650 | Zoledronic acid | None | Tooth extraction | o | |
Digestive tract surgery | Colorectal cancer | 574 | Zoledronic acid | Continuation | Tooth extraction | o | |
Department of Allergy and Respiratory Medicine | Breast cancer | 1540 | Zoledronic acid | Continuation | None | o | |
Breast and Endocrine Surgery Department | Breast cancer | 65 | Denosumab | Continuation | Tooth extraction | o | |
Department of Allergy and Respiratory Medicine | Lung cancer | 1071 | Zoledronic acid Denosumab | Continuation | None | | o |
Breast and Endocrine Surgery Department | Breast cancer | 1086 | Zoledronic acid Denosumab | Continuation | None | o | |
Department of Allergy and Respiratory Medicine | Kidney cancer | 186 | Denosumab | Continuation | Tooth extraction | o | |
Breast and Endocrine Surgery Department | Breast cancer | 2582 | Zoledronic acid | Continuation | None | 0 | |